Cargando…
Expression of immune checkpoint molecules programmed death protein 1, programmed death‐ligand 1 and inducible T‐cell co‐stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome
BACKGROUND: The relationship between immune checkpoint status and disease outcome is a major focus of research in cutaneous T‐cell lymphoma (CTCL), a disfiguring neoplastic dermatological disorder. Mycosis fungoides (MF) and Sézary syndrome (SS) are the two most common types of CTCL. OBJECTIVES: The...
Autores principales: | Di Raimondo, Cosimo, Rubio‐Gonzalez, Belen, Palmer, Joycelynne, Weisenburger, Dennis D., Zain, Jasmine, Wu, Xiwei, Han, Zhen, Rosen, Steven T., Song, Joo Y., Querfeld, Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357001/ https://www.ncbi.nlm.nih.gov/pubmed/35194801 http://dx.doi.org/10.1111/bjd.21063 |
Ejemplares similares
-
Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021) -
Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023) -
Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides
por: Di Raimondo, Cosimo, et al.
Publicado: (2021) -
The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015) -
TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)